CZ20032111A3 - Krystalické formy pyrimidinového nukleosidového derivátu - Google Patents

Krystalické formy pyrimidinového nukleosidového derivátu

Info

Publication number
CZ20032111A3
CZ20032111A3 CZ20032111A CZ20032111A CZ20032111A3 CZ 20032111 A3 CZ20032111 A3 CZ 20032111A3 CZ 20032111 A CZ20032111 A CZ 20032111A CZ 20032111 A CZ20032111 A CZ 20032111A CZ 20032111 A3 CZ20032111 A3 CZ 20032111A3
Authority
CZ
Czechia
Prior art keywords
crystalline forms
pyrimidine nucleoside
nucleoside derivative
derivative
pyrimidine
Prior art date
Application number
CZ20032111A
Other languages
English (en)
Other versions
CZ303241B6 (cs
Inventor
Takashi Takita
Kelichi Ohtsuka
Eiji Numagami
Susumu Harashima
Original Assignee
Sankyo Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Company Limited filed Critical Sankyo Company Limited
Publication of CZ20032111A3 publication Critical patent/CZ20032111A3/cs
Publication of CZ303241B6 publication Critical patent/CZ303241B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
CZ20032111A 2001-02-09 2002-02-06 Krystalické formy pyrimidinového nukleosidového derivátu CZ303241B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001033128 2001-02-09

Publications (2)

Publication Number Publication Date
CZ20032111A3 true CZ20032111A3 (cs) 2003-12-17
CZ303241B6 CZ303241B6 (cs) 2012-06-13

Family

ID=18896929

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20032111A CZ303241B6 (cs) 2001-02-09 2002-02-06 Krystalické formy pyrimidinového nukleosidového derivátu

Country Status (21)

Country Link
EP (1) EP1364959B1 (cs)
JP (2) JP3748536B2 (cs)
KR (1) KR100679904B1 (cs)
CN (1) CN100408591C (cs)
AT (1) ATE361929T1 (cs)
AU (1) AU2002230164B2 (cs)
BR (2) BRPI0207102A8 (cs)
CA (1) CA2437994C (cs)
CY (1) CY1106685T1 (cs)
CZ (1) CZ303241B6 (cs)
DE (1) DE60220024T2 (cs)
DK (1) DK1364959T3 (cs)
ES (1) ES2286237T3 (cs)
HU (1) HU229294B1 (cs)
IL (2) IL157216A0 (cs)
MX (1) MXPA03007123A (cs)
NZ (1) NZ527393A (cs)
PT (1) PT1364959E (cs)
RU (1) RU2256666C2 (cs)
WO (1) WO2002064609A1 (cs)
ZA (1) ZA200306121B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2081419B1 (en) 1999-09-02 2013-08-07 Ibiden Co., Ltd. Printed circuit board and method of manufacturing printed circuit board
CN101232776B (zh) 1999-09-02 2011-04-20 揖斐电株式会社 印刷布线板
GB0526419D0 (en) 2005-12-23 2006-02-08 Cyclacel Ltd Formulation
GB0625283D0 (en) 2006-12-19 2007-01-24 Cyclacel Ltd Combination
JP5066737B2 (ja) * 2007-04-06 2012-11-07 大鵬薬品工業株式会社 シチジン誘導体を含有する持続静脈内投与用抗腫瘍剤
US8124593B2 (en) 2007-11-05 2012-02-28 Cyclacel Limited Methods of treatment using sapacitabine
GB0808357D0 (en) * 2008-05-08 2008-06-18 Cyclacel Ltd Process
PL2307002T3 (pl) 2008-06-09 2013-05-31 Cyclacel Ltd Kombinacje sapacytabiny lub cndac z inhibitorami metylotransferazy dna, takimi jak decytabina i prokaina
PL2696878T3 (pl) 2011-04-14 2020-01-31 Cyclacel Limited Schemat dawkowania dla sapacytabiny i decytabiny w kombinacji do leczenia ostrej białaczki szpikowej
ES2880109T3 (es) 2012-03-15 2021-11-23 Celgene Car Llc Formas sólidas de un inhibidor de la cinasa del receptor del factor de crecimiento epidérmico
ES2963057T3 (es) * 2015-03-09 2024-03-25 Grace W R & Co Forma cristalina de ribósido de nicotinamida
EP3727400A4 (en) 2017-12-22 2021-10-20 Elysium Health, Inc. CRYSTALLINE FORMS OF NICOTINAMIDE RIBOSIDE CHLORIDE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2559917B2 (ja) * 1990-06-15 1996-12-04 三共株式会社 ピリミジンヌクレオシド誘導体
FI105556B (fi) * 1991-09-30 2000-09-15 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta

Also Published As

Publication number Publication date
HUP0303159A3 (en) 2007-06-28
AU2002230164B2 (en) 2005-04-07
HUP0303159A2 (hu) 2003-12-29
BRPI0207102A8 (pt) 2018-02-27
KR100679904B1 (ko) 2007-02-07
CA2437994C (en) 2011-05-17
WO2002064609A1 (en) 2002-08-22
CN1501939A (zh) 2004-06-02
KR20030081424A (ko) 2003-10-17
IL157216A0 (en) 2004-02-19
ES2286237T3 (es) 2007-12-01
CY1106685T1 (el) 2012-05-23
HU229294B1 (en) 2013-10-28
EP1364959B1 (en) 2007-05-09
ZA200306121B (en) 2005-01-26
CA2437994A1 (en) 2002-08-22
DK1364959T3 (da) 2007-06-04
EP1364959A1 (en) 2003-11-26
NZ527393A (en) 2004-07-30
PT1364959E (pt) 2007-07-23
RU2256666C2 (ru) 2005-07-20
ATE361929T1 (de) 2007-06-15
BR0207102A (pt) 2004-01-27
JP4356998B2 (ja) 2009-11-04
DE60220024T2 (de) 2007-11-22
JP2006008699A (ja) 2006-01-12
EP1364959A4 (en) 2004-03-24
CN100408591C (zh) 2008-08-06
IL157216A (en) 2008-03-20
MXPA03007123A (es) 2003-11-18
JP2002308895A (ja) 2002-10-23
JP3748536B2 (ja) 2006-02-22
RU2003124648A (ru) 2005-02-27
DE60220024D1 (en) 2007-06-21
CZ303241B6 (cs) 2012-06-13

Similar Documents

Publication Publication Date Title
IL160872A0 (en) Pyrimidinones as melanin concentrating hormone receptor 1
CY1106685T1 (el) Κρυσταλλος παραγωγου πυριμιδινο νουκλεοζιτη
MA28172A1 (fr) 5,7-diaminopyrazolo [4,3-D] pyrimidines à activité inhibitrice de PDE-5
BR0210030A (pt) Derivado de fenilpiridinacarbonilpiperazina
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
CY1111759T1 (el) Ενδιαμεσες ενωσεις για την παρασκευη συγκεκριμενων τριαζολοπυριμιδινων ως ρ2τ ανταγωνιστων
HK1053831A1 (zh) 作为治疗药物的激酶抑制剂
PT1448853E (pt) Melhoramentos relacionados com branqueadores ópticos
ZA200309887B (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
PL369530A1 (en) Chemical compounds
IS8825A (is) Ný kristölluð og myndlaus form af tríasól (4,5-D) pýrimídínefnasambandi
MXPA03009604A (es) Compuestos de espiropirazol.
AU2001277753A1 (en) Phosphonocephem compound
YU82303A (sh) Analozi nociceptina
MXPA02004440A (es) Derivados de pirrol como inhibidores de la fosfodiesterasa vii.
MXPA03009602A (es) Analogos de nociceptina.
SE0103710D0 (sv) Compounds
CA2452036A1 (en) 6-'2-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity
UY27250A1 (es) Fenil-heterociclil-cteres
BR0313976A (pt) Compostos de 7-fenilpirazolopiridina
GB0215392D0 (en) Chemical compounds
ES2185599T3 (es) Preparacion de intermediarios de la imidazodiacepina.
EP1557407A4 (en) NEW ALPHA-CETOAMIDE DERIVATIVE AND USE THEREOF
AU2002314622A1 (en) Compound of formula (xr5-)(y+), process for synthesis

Legal Events

Date Code Title Description
MK4A Patent expired

Effective date: 20220206